MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. Care4Rare, led out of the CHEO Research Institute affiliated with the University of Ottawa,... Read more
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins WALTHAM, Mass., Jan. 5, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash... Read more
Full spectrum of innovative solutions empowers better heart care and builds efficiency across the care pathway SINGAPORE — 5 Jan 2022: GE Healthcare announced a collaboration with Boston Scientific to provide a comprehensive solution offering, from diagnostic to percutaneous coronary intervention (PCI) to cardiac care centers in Southeast Asia, which also means easier access to... Read more
The above image displaying ribosomal biogenesis and blood vessels in developing zebrafish embryos was awarded first prize in the life sciences category of the LMA/VIA 2021 Image Competition (sponsored by ZEISS) of the Australian Microscopy & Microanalysis Society. Dr. Kazuhide Shaun Okuda, Postdoctoral Fellow at the Hogan laboratory, Peter MacCallum Cancer Centre in Victoria, Australia, took... Read more
MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, at 12:00 pm Eastern Time (9:00 am Pacific Time) The live webcast can be accessed at the company’s investors page at... Read more
Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference WALTHAM, Mass., Jan. 4, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11,... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 40th annual J.P. Morgan Healthcare Conference, to be held virtually on January 10-13, 2022. Frank Laukien, Chairman, President & CEO and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 10th, 2022 at... Read more
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 2, 2022 WALTHAM, Mass., Jan. 3, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2021 before the market opens on Wednesday, February 2, 2022,... Read more
Craniofacial development is a complex morphogenetic process that requires a precise interplay of multiple cell and tissue types to generate the frontonasal skeleton. Disruption of this process results in highly prevalent human birth defects such as cleft lip and palate. Dr. Katherine Fantauzzo is an Assistant Professor in the Department of Craniofacial Biology at the... Read more
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference WALTHAM, Mass., Dec. 30, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on Thursday,... Read more